Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy F Ciceri, A Castagna, P Rovere-Querini, F De Cobelli, A Ruggeri, L Galli, ... Clinical immunology 217, 108509, 2020 | 332 | 2020 |
Pentraxin-3 as a marker of disease activity in Takayasu arteritis L Dagna, F Salvo, M Tiraboschi, EP Bozzolo, S Franchini, C Doglioni, ... Annals of internal medicine 155 (7), 425-433, 2011 | 195 | 2011 |
Efficacy of traditional and biologic agents in different clinical phenotypes of adult‐onset Still's disease S Franchini, L Dagna, F Salvo, P Aiello, E Baldissera, MG Sabbadini Arthritis & Rheumatism 62 (8), 2530-2535, 2010 | 153 | 2010 |
Platelet microparticles sustain autophagy-associated activation of neutrophils in systemic sclerosis N Maugeri, A Capobianco, P Rovere-Querini, GA Ramirez, E Tombetti, ... Science translational medicine 10 (451), eaao3089, 2018 | 152 | 2018 |
Circulating platelets as a source of the damage-associated molecular pattern HMGB1 in patients with systemic sclerosis N Maugeri, S Franchini, L Campana, M Baldini, GA Ramirez, ... Autoimmunity 45 (8), 584-587, 2012 | 117 | 2012 |
Treatment of refractory Takayasu arteritis with tocilizumab: 7 Italian patients from a single referral center E Tombetti, S Franchini, M Papa, MG Sabbadini, E Baldissera The Journal of rheumatology 40 (12), 2047-2051, 2013 | 102 | 2013 |
Predictors of pneumothorax/pneumomediastinum in mechanically ventilated COVID-19 patients A Belletti, D Palumbo, A Zangrillo, EV Fominskiy, S Franchini, ... Journal of cardiothoracic and vascular anesthesia 35 (12), 3642-3651, 2021 | 91 | 2021 |
Independent association of anti–β2‐glycoprotein I antibodies with macrovascular disease and mortality in scleroderma patients F Boin, S Franchini, E Colantuoni, A Rosen, FM Wigley, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2009 | 76 | 2009 |
Efficacy and safety of biological agents in adult-onset Still’s disease G Cavalli, S Franchini, P Aiello, B Guglielmi, A Berti, C Campochiaro, ... Scandinavian journal of rheumatology 44 (4), 309-314, 2015 | 75 | 2015 |
Safety and efficacy of topical infliximab in a mouse model of ocular surface scarring G Ferrari, F Bignami, C Giacomini, S Franchini, P Rama Investigative ophthalmology & visual science 54 (3), 1680-1688, 2013 | 74 | 2013 |
Pregnancy outcomes in patients with systemic autoimmunity V Canti, MT Castiglioni, S Rosa, S Franchini, MG Sabbadini, AA Manfredi, ... Autoimmunity 45 (2), 169-175, 2012 | 48 | 2012 |
Stranger months: how SARS-CoV-2, fear of contagion, and lockdown measures impacted attendance and clinical activity during February and March 2020 at an urban Emergency … S Franchini, M Spessot, G Landoni, C Piani, C Cappelletti, F Mariani, ... Disaster Medicine and Public Health Preparedness 15 (5), e33-e42, 2021 | 47 | 2021 |
High flow nasal cannula oxygen vs. conventional oxygen therapy and noninvasive ventilation in emergency department patients: a systematic review and meta-analysis V Tinelli, L Cabrini, E Fominskiy, S Franchini, L Ferrante, L Ball, P Pelosi, ... The Journal of Emergency Medicine 57 (3), 322-328, 2019 | 44 | 2019 |
The role of platelets in the pathogenesis of systemic sclerosis GA Ramirez, S Franchini, P Rovere-Querini, MG Sabbadini, AA Manfredi, ... Frontiers in Immunology 3, 160, 2012 | 44 | 2012 |
Adult-onset Still's disease: clinical presentation in a large cohort of Italian patients S Franchini, L Dagna, F Salvo, P Aiello, E Baldissera, MG Sabbadini Clinical & Experimental Rheumatology 28 (1), 41, 2010 | 43 | 2010 |
Biobanking for COVID-19 research P Medica Panminerva Medica, 2020 | 39 | 2020 |
SIRS or qSOFA? Is that the question? Clinical and methodological observations from a meta-analysis and critical review on the prognostication of patients with suspected sepsis … S Franchini, L Scarallo, M Carlucci, L Cabrini, M Tresoldi Internal and Emergency Medicine 14, 593-602, 2019 | 31 | 2019 |
qSOFA should replace SIRS as the screening tool for sepsis S Franchini, A Duca Critical Care 20, 1-2, 2016 | 29 | 2016 |
A radiological predictor for pneumomediastinum/pneumothorax in COVID-19 ARDS patients D Palumbo, A Zangrillo, A Belletti, G Guazzarotti, MR Calvi, F Guzzo, ... Journal of Critical Care 66, 14-19, 2021 | 23 | 2021 |
Coronary Microvascular Dysfunction in Asymptomatic Patients Affected by Systemic Sclerosis–Limited vs. Diffuse Form– A Faccini, M Oppizzi, A Margonato, M Galderisi, MG Sabbadini, ... Circulation Journal 79 (4), 825-829, 2015 | 22 | 2015 |